These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 456013)

  • 21. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prajmalium bitartrate in chronic ventricular arrhythmias: comparison with disopyramide.
    Chiariello M; Indolfi C; Cappelli Bigazzi M; Condorelli M
    Eur J Clin Pharmacol; 1983; 24(1):35-9. PubMed ID: 6832199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of disopyramide in the treatment of arrhythmias in ambulatory patients.
    Jones MB
    J Int Med Res; 1976; 4(1 Suppl):86-9. PubMed ID: 1026536
    [No Abstract]   [Full Text] [Related]  

  • 24. Disopyramide: a new agent for effective therapy of ventricular dysrhythmias.
    Mason DT
    Drugs; 1978 May; 15(5):329-30. PubMed ID: 657990
    [No Abstract]   [Full Text] [Related]  

  • 25. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial.
    Trimarco B; Volpe M; Ricciardelli B; Sacca' L; De Luca N; Rengo F; Condorelli M
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute termination of cardiac arrhythmias with intravenous disopyramide.
    Ee BK; Chia BL; Ng RA; Oh V; Tan AT; Choo M
    Singapore Med J; 1982 Aug; 23(4):185-90. PubMed ID: 7178900
    [No Abstract]   [Full Text] [Related]  

  • 28. [Action of injected disopyramide on ventricular arrhythmias and atrioventricular conduction].
    Vogel M; Desoutter P; Bellanger P; Motté G; Welti JJ
    Arch Mal Coeur Vaiss; 1976 Apr; 69(4):395-406. PubMed ID: 59581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind trial of disopyramide, procaineamide and digoxin in paroxysmal suptraventricular tachycardia.
    Millar-Craig MW; Raftery EB
    Clin Cardiol; 1979 Jun; 2(3):179-84. PubMed ID: 389512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventive disopyramide in patients with ventricular arrhythmias detected by exercise].
    Cardonne A; Pérez-Medina T; García-Barreto D
    Arch Inst Cardiol Mex; 1976; 46(1):69-73. PubMed ID: 779692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias.
    Myers JB; Millar RN; Obel IW
    S Afr Med J; 1978 Dec; 54(26):1083-9. PubMed ID: 746466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of hemodynamic and electrocardiographic changes following intravenous disopyramide.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1979; 205(5):417-23. PubMed ID: 443082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The electrophysiology of Norpace (Part III).
    Caracta A
    Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
    [No Abstract]   [Full Text] [Related]  

  • 34. Analysis of heart rate variability in a patient with paroxysmal atrial fibrillation.
    van den Berg MP; Haaksma J; Brouwer J; Crijns HJ; Lie KI
    Eur Heart J; 1995 Dec; 16(12):2011-2. PubMed ID: 8682048
    [No Abstract]   [Full Text] [Related]  

  • 35. Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
    Green AG
    Scott Med J; 1979 Jan; 24(1):21-4. PubMed ID: 91197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experiences with the antiarrhythmic therapy using disopyramide].
    Hombach V; Freyland MD; Steffel D; Braun V; Höpp HW; Zanker R; Behrenbeck DW; Tauchert M; Hilger HH
    Med Welt; 1981 Apr; 32(14):458-64. PubMed ID: 7219159
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative study of the antiarrhythmic efficacy of mexiletine and disopyramide in patients with chronic ventricular arrhythmias.
    Breithardt G; Seipel L; Lersmacher J; Abendroth RR
    J Cardiovasc Pharmacol; 1982; 4(2):276-84. PubMed ID: 6175812
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of oral disopyramide phosphate on induction of paroxysmal supraventricular tachycardia.
    Swiryn S; Bauernfeind RA; Wyndham CR; Dhingra RC; Palileo E; Strasberg B; Rosen KM
    Circulation; 1981 Jul; 64(1):169-75. PubMed ID: 7237716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of disopyramide in resistant cardiac arrhythmias due to acute ischaemic heart disease.
    Sandler G
    J Int Med Res; 1977; 5(5):369-73. PubMed ID: 913864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind, parallel group comparison of disopyramide phosphate and quinidine in patients with cardiac arrhythmias.
    Arif M; Laidlaw JC; Oshrain C; Willis PW; Nissen CH; McDermott DJ; Smith WS; Karim A; Wilson RR
    Angiology; 1983 Jun; 34(6):393-400. PubMed ID: 6408949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.